Human malaria in immunocompromised mice: New in vivo model for chemotherapy studies

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 6, 2001, Pages 1847-1853

  Moreno, A ^a   Badell, E ^a   Van Rooijen, N ^b   Druilhe, P ^a  

^a INSTITUT PASTEUR   (France)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; DIHYDROARTEMISININ; MEFLOQUINE; QUININE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DRUG EFFICACY; DRUG SENSITIVITY; FEMALE; IMMUNE DEFICIENCY; MALARIA; MALE; MOUSE; NONHUMAN; PARASITEMIA; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

ANIMALS; ANTIMALARIALS; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; MALARIA, FALCIPARUM; MALE; MICE; MODELS, BIOLOGICAL; PLASMODIUM FALCIPARUM;

EID: 0035008536     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.6.1847-1853.2001     Document Type: Article

References (42)

1. Badell, E., V. Pasquetto, N. Van Rooijen, and P. Druilhe. 1995. A mouse model for human malaria erythrocytic stages. Parasitol. Today 11:235-237.
2. Badell, E., C. Oeuvray, A. Moreno, S. Soe, N. Van Rooijen, A. Bouzidi, and P. Druilhe. 2000. Human malaria in immunocompromised mice: an in vivo model to study defense mechanisms against Plasmodium falciparum. J. Exp. Med. 192(11):1653-1660.
3. Baptista, J. L., I. Das Neves, U. D'Alessandro, L. Hendrix, and M. Wery. 1997. Plasmodium falciparum chloroquine and quinine sensitivity in asymptomatic and symptomatic children in Sao Tome Island. Trop. Med. Int. Health 2:582-588.
4. Brasseur, P., P. Druilhe, J. Kouamouo, O. Brandicourt, M. Danis, and S. R. Moyou. 1986. High level of sensitivity to chloroquine of 72 Plasmodium falciparum isolates from southern Cameroon in January 1985. Am. J. Trop. Med. Hyg. 35:711-716.
5. Brasseur, P., J. Kouamouo, O. Brandicourt, R. Moyou-Somo, and P. Druilhe. 1988. Patterns of in vitro resistance to chloroquine, quinine, and mefloquine of Plasmodium falciparum in Cameroon, 1985-1986. Am. J. Trop. Med. Hyg. 39:166-172.
6. Chongsuphajaisiddhi, T., A. Sabchareon, P. Chantavanich, V. Singhasivanon, P. Attanath, W. H. Wernsdorfer, and U. K. Sheth. 1987. A phase-III clinical trial of mefloquine in children with chloroquine-resistant falciparum malaria in Thailand. Bull. W. H. O. 65:223-226.
7. De Vries, P. J., K. D. Tran, X. K. Nguyen, B. Le Nguyen, T. Y. Pham, D. D. Dao, C. J. Van Boxtel, and P. A. Kager. 1997. The pharmacokinetics of a single dose of artemisinin in patients with uncomplicated falciparum malaria. Am. J. Trop. Med. Hyg. 56:503-507.
8. Druilhe, P., O. Brandicourt, T. Chongsuphajaisiddhi, and J. Berthe. 1988. Activity of a combination of three cinchona bark alkaloids against Plasmodium falciparum in vitro. Antimicrob. Agents Chemother. 32:250-254.
9. Druilhe, P., A. Moreno, C. Blanc, P. Brasseur, and P. Jacquier. A colorimetric in vitro sensitivity assay for Plasmodium falciparum based on a highly sensitive double-site pLDH antigen capture ELISA. Am. J. Trop. Med. Hyg., in press.
10. Elueze, E. I., J. O. Osisanya, and I. O. Edafiogho. 1990. Sensitivity to chloroquine in vivo and in vitro of Plasmodium falciparum in Sokoto, Nigeria. Trans. R. Soc. Trop. Med. Hyg. 84:45.
11. Fowler, V. G., Jr., M. Lemnge, S. G. Irare, E. Malecela, J. Mhina, S. Mtui, M. Mashaka, and R. Mtoi. 1993. Efficacy of chloroquine on Plasmodium falciparum transmitted at Amani, eastern Usambara Mountains, north-east Tanzania: an area where malaria has recently become endemic. J. Trop. Med. Hyg. 96:337-345.
12. Freireich, E. J., E. A. Gehan, D. P. Rail, L. H. Schmidt, and H. E. Skipper. 1966. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemother. Rep. 50:219-244.
13. Fryauff, D. J., J. K. Baird, D. Candradikusuma, S. Masbar, M. A. Sutamihardja, B. Leksana, S. Tuti, H. Marwoto, T. Richie, and A. Romzan. 1997. Survey of in vivo sensitivity to chloroquine by Plasmodium falciparum and P. vivax in Lombok, Indonesia. Am. J. Trop. Med. Hyg. 56:241-244.
14. Ha, V., N. H. Nguyen, T. B. Tran, M. C. Bui, H. P. Nguyen, T. H. Tran, T. Q. Phan, and K. Arnold. 1997. Severe and complicated malaria treated with artemisinin, artesunate or artemether in Viet Nam. Trans. R. Soc. Trop. Med. Hyg. 91:465-467.
15. Harinasuta, T., D. Bunnag, and W. H. Wernsdorfer. 1983. A phase II clinical trial of mefloquine in patients with chloroquine-resistant falciparum malaria in Thailand. Bull. W. H. O. 61:299-305.
16. Hassan Alin, M., M. Ashton, C. M. Kihamia, G. J. Mtey, and A. Bjorkman. 1996. Multiple dose pharmacokinetics of oral artemisinin and comparison of its efficacy with that of oral artesunate in falciparum malaria patients. Trans. R. Soc. Trop. Med. Hyg. 90:61-65.
17. Jacobs, G. H., M. Aikawa, W. K. Milhous, and J. R. Rabbege. 1987. An ultrastructural study of the effects of mefloquine on malaria parasites. Am. J. Trop. Med. Hyg. 36:9-14.
18. Jiang, J. B., G. Q. Li, X. B. Guo, Y. C. Kong, and K. Arnold. 1982. Antimalarial activity of mefloquine and qinghaosu. Lancet ii:285-288.
19. Kombila, M., T. H. Duong, D. Dufillot, J. Koko, V. Guiyedi, C. Guiguen, A. Ferrer, and D. Richard-Lenoble. 1997. Light microscopic changes in Plasmodium falciparum from Gahonese children treated with artemether. Am. J. Trop. Med. Hyg. 57:643-645.
20. Lambros, C., and J. P. Vanderberg. 1979. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J. Parasitol. 65:418-420.
21. Lopez, A. F., M. Strath, and C. J. Sanderson. 1984. Differentiation antigens on mouse eosinophils and neutrophils identified by monoclonal antibodies. Br. J. Haematol. 57:489-494.
22. Luxemburger, C., F. Nosten, S. D. Raimond, T. Chongsuphajaisiddhi, and N. J. White. 1995. Oral artesunate in the treatment of uncomplicated hyperparasitemic falciparum malaria. Am. J. Trop. Med. Hyg. 53:522-525.
23. Masaba, S. C., and H. C. Spencer. 1982, Sensitivity of Plasmodium falciparum to chloroquine in Busia District, Kenya. Trans. R. Soc. Trop. Med. Hyg. 76:314-316.
24. Nguyen-Dinh, P., I. K. Schwartz, J. D. Sexton, B. Egumb, B. Bolange, K. Ruti, N. Nkuku-Pela, and M. Wery. 1985. In vivo and in vitro susceptibility to chloroquine of Plasmodium falciparum in Kinshasa and Mbuji-Mayi, Zaire. Bull. W. H. O. 63:325-330.
25. Olliaro, P., F. Castelli, S. Caligaris, P. Druilhe, and G. Carosi. 1989. Ultrastructure of Plasmodium falciparum "in vitro". II. Morphological patterns of different quinolines effects. Microbiologica 12:15-28.
26. Olliaro, P., J. Cattani, and D. Wirth. 1996. Malaria, the submerged disease. J. Am. Med. Assoc. 275:230-233.
27. Peters, W. 1970. Chemotherapy and drug resistance in malaria, p. 94-99. Academic Press, Inc., New York, N.Y.
28. Peters, W. 1975. The chemotherapy of rodent malaria. XXII. The value of drug-resistant strains of P. berghei in screening for blood schizontocidal activity. Ann. Trop. Med. Parasitol. 69:155-171.
29. Reese, R. T., S. G. Langreth, and W. Trager. 1979. Isolation of stages of the human parasite Plasmodium falciparum from culture and from animal blood. Bull. W. H. O. 57:53-61.
30. Roche, J., A. Benito, S. Ayecaba, C. Amela, R. Molina, and J. Alvar. 1993. Resistance of Plasmodium falciparum to antimalarial drugs in Equatorial Guinea. Ann. Trop. Med. Parasitol. 87:443-449.
31. Salako, L. A., A. Sowunmi, and O. J. Laoye. 1988. Evaluation of the sensitivity in vivo and in vitro of Plasmodium falciparum malaria to quinine in an area of full sensitivity to chloroquine. Trans. R. Soc. Trop. Med. Hyg. 82:366-368.
32. Schmidt, L. H. 1978. Plasmodium falciparum and Plasmodium vivax infections in the owl monkey (Aotus trivirgatus). II. Responses to chloroquine, quinine, and pyrimethamine. Am. J. Trop. Med. Hyg. 27:703-717.
33. Schmidt, L. H. 1978. Plasmodium falciparum and Plasmodium vivax infections in the owl monkey (Aotus trivirgatus). III. Methods employed in the search for new blood schizonticidal drugs. Am. J. Trop. Med. Hyg. 27:718-737.
34. Skinner, T. S., L. S. Manning, W. A. Johnston, and T. M. Davis. 1996. In vitro stage-specific sensitivity of Plasmodium falciparum to quinine and artemisinin drugs. Int. J. Parasitol. 26:519-525.
35. Smithuis, F. M., J. B. van Woensel, E. Nordlander, W. S. Vantha, and F. O. ter Kuile. 1993. Comparison of two mefloquine regimens for treatment of Plasmodium falciparum malaria on the northeastern Thai-Cambodian border. Antimicrob. Agents Chemother. 37:1977-1981.
36. Sowunmi, A., A. M. Oduola, L. A. Salako, O. A. Ogundahunsi, O. J. Laoye, and O. Walker. 1992. The relationship between the response of Plasmodium falciparum malaria to mefloquine in African children and its sensitivity in vitro. Trans. R. Soc. Trop. Med. Hyg. 86:368-371.
37. Sowunmi, A., L. A. Salako, O. Walker, and O. A. Ogundahunsi. 1990. Clinical efficacy of mefloquine in children suffering from chloroquine-resistant Plasmodium falciparum malaria in Nigeria. Trans. R. Soc. Trop. Med. Hyg. 84:761-764.
38. Spencer, H. C., S. C. Masaba, and D. Kiaraho. 1982. Sensitivity of Plasmodium falciparum isolates to chloroquine in Kisumu and Malindi, Kenya. Am. J. Trop. Med. Hyg. 31:902-906.
39. Tin, F., N. Hlaing, and R. Lasserre. 1982. Single-dose treatment of falciparum malaria with mefloquine: field studies with different doses in semi-immune adults and children in Burma. Bull. W. H. O. 60:913-917.
40. Van Rooijen, N. 1989. The liposome-mediated macrophage 'suicide' technique. J. Immunol. Methods 124:1-6.
41. Walker, O., L. A. Salako, P. O. Obib, K. Bademosi, and O. Sodeinde. 1984. The sensitivity of Plasmodium falciparum to chloroquine and amodiaquine in Ihadan, Nigeria. Trans. R. Soc. Trop. Med. Hyg. 78:782-784.
42. World Health Organization. 1973. Chemotherapy of malaria and resistance to antimalarials. WHO Tech. Rep. Ser. 529:1-121.